To better understand the implications of elevated B‐ and CD4+ T‐cell frequencies in MS, we further analyzed whether T‐bet and CXCR3, as markers of CD4+ T‐cell interaction and CNS‐homing, are differentially expressed by B cells in the MS versus the RDD and AE groups. Here, CD4 is linked to myeloid sarcoma.